AMRX and AMGN Related Headlines

Go Back

Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'

AMRX and AMGN Related Press Releases

Go Back

AMRX and AMGN Related SEC Filings

Go Back